{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T06:40:24Z","timestamp":1707547224328},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:00:00Z","timestamp":1168992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2007,2,7]]},"DOI":"10.1007\/s00228-006-0242-8","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T19:52:36Z","timestamp":1168977156000},"page":"221-228","source":"Crossref","is-referenced-by-count":17,"title":["Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals"],"prefix":"10.1007","volume":"63","author":[{"given":"N.","family":"Tavassoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Duchayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sadaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Desboeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Muoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Honorato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,17]]},"reference":[{"key":"242_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00012995-200110000-00001","volume":"210","author":"PJ Medina","year":"2001","unstructured":"Medina PJ, George JN (2001) Drug-associated blood dyscrasias. Adv Drug React Bull 210:803\u2013806","journal-title":"Adv Drug React Bull"},{"key":"242_CR2","first-page":"148","volume-title":"The drug etiology of agranulocytosis and aplastic anemia","author":"DW Kaufman","year":"1991","unstructured":"Kaufman DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia. Oxford University Press, New York"},{"key":"242_CR3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/B:EJEP.0000032371.97823.85","volume":"19","author":"H Theophile","year":"2004","unstructured":"Theophile H, Begaud B, Martin K, Laporte JR, Capella D (2004) Incidence of agranulocytosis in southwest France. Eur J Epidemiol 19:563\u2013565","journal-title":"Eur J Epidemiol"},{"key":"242_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2005.06.008","volume":"27","author":"E Andr\u00e8s","year":"2006","unstructured":"Andr\u00e8s E, Maloisel F (2006) Idiosyncratic drug-induced agranulocytosis. Rev Med Int 27:209\u2013214","journal-title":"Rev Med Int"},{"key":"242_CR5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.1992.00400190095018","volume":"152","author":"BL Strom","year":"1992","unstructured":"Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M (1992) Descriptive epidemiology of agranulocytosis. Arch Intern Med 152:1475\u20131480","journal-title":"Arch Intern Med"},{"key":"242_CR6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.1994.03510360061038","volume":"271","author":"NS Young","year":"1994","unstructured":"Young NS (1994) Agranulocytosis. JAMA 271:935\u2013938","journal-title":"JAMA"},{"key":"242_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.1996.tb01641.x","volume":"60","author":"DW Kaufman","year":"1996","unstructured":"Kaufman DW, Kelly JP, Jurgelon JM et al (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 60:23\u201330","journal-title":"Eur J Haematol Suppl"},{"key":"242_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","volume":"79","author":"A Julia","year":"1991","unstructured":"Julia A, Olona M, Bueno J et al (1991) Drug induced agranulocytosis: pronostic factors in a series of 168 episodes. Br J Haematol 79:366\u2013371","journal-title":"Br J Haematol"},{"key":"242_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/oxfordjournals.eurheartj.a059953","volume":"12","author":"L Ibanez","year":"1991","unstructured":"Ibanez L, Juan J, Perez E, Carne X, Laporte J-R (1991) Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach. Eur Heart J 12:639\u2013641","journal-title":"Eur Heart J"},{"key":"242_CR10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/archinte.1993.00410180065007","volume":"153","author":"BL Strom","year":"1993","unstructured":"Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE (1993) Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 153:2119\u20132124","journal-title":"Arch Intern Med"},{"key":"242_CR11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0895-4356(98)00072-9","volume":"51","author":"NSB Rawson","year":"1998","unstructured":"Rawson NSB, Harding SR, Malcolm E, Lueck L (1998) Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol 51:1343\u20131355","journal-title":"J Clin Epidemiol"},{"key":"242_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM Klauw Van der","year":"1999","unstructured":"Van der Klauw MM, Goudsmit R, Halie MR et al (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 159:369\u2013374","journal-title":"Arch Intern Med"},{"key":"242_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00315580","volume":"38","author":"JR Laporte","year":"1990","unstructured":"Laporte JR, Capella D, Juan J (1990) Agranulocytosis induced by cinepazide. Eur J Clin Pharmacol 38:387\u2013388","journal-title":"Eur J Clin Pharmacol"},{"key":"242_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s002280050011","volume":"55","author":"L Ibanez","year":"2000","unstructured":"Ibanez L, Ballarin E, Perez E, Vidal X, Capella D, Laporte JR (2000) Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug. Eur J Clin Pharmacol 55:761\u2013764","journal-title":"Eur J Clin Pharmacol"},{"key":"242_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s002280000190","volume":"56","author":"L Ibanez","year":"2000","unstructured":"Ibanez L, Ballarin E, Vidal X, Laporte JR (2000) Agranulocytosis associated with calcium dobesilate: clinical course and risk estimation with the case-control and the case-population approaches. Eur J Clin Pharmacol 56:763\u2013767","journal-title":"Eur J Clin Pharmacol"},{"key":"242_CR16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165:869\u2013874","journal-title":"Arch Intern Med"},{"key":"242_CR17","volume-title":"Adverse drug reactions: a practical guide to diagnosis and management","author":"Ch Benichou","year":"1994","unstructured":"Benichou Ch (1994) Adverse drug reactions: a practical guide to diagnosis and management. Wiley, Chichester"},{"key":"242_CR18","unstructured":"No authors listed (1991) Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. Int J Clin Pharmacol Ther Toxicol 29:75\u201381"},{"key":"242_CR19","unstructured":"Cancer Therapy Evaluation Program (2003) Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. http:\/\/www.ctep.cancer.gov\/forms\/CTCAEv3.pdf"},{"key":"242_CR20","unstructured":"Uppsala Monitoring Centre (2006) The use of the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) system for standardised case causality assessment. http:\/\/www.who-umc.org\/graphics\/4409.pdf"},{"key":"242_CR21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255\u201359","journal-title":"Lancet"},{"key":"242_CR22","unstructured":"Anonymous (2006) Dictionnaire VIDAL, 82th edn. OVP, Paris"},{"key":"242_CR23","unstructured":"No authors listed (2005) Cat\u00e1logo de especialidades farmac\u00e9uticas. Consejo General de Colegios de Farmac\u00e9uticos, Madrid"},{"key":"242_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0895-4356(92)90088-5","volume":"45","author":"P Tubert","year":"1992","unstructured":"Tubert P, B\u00e9gaud B, P\u00e9r\u00e9 JC, Haramburu F, Lellouch J (1992) Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol 45:283\u2013286","journal-title":"J Clin Epidemiol"},{"key":"242_CR25","volume-title":"Estimation of under-reporting. Methodological approaches in pharmacoepidemiology: application to spontaneous reporting ARME-P","author":"F Haramburu","year":"1993","unstructured":"Haramburu F (1993) Estimation of under-reporting. Methodological approaches in pharmacoepidemiology: application to spontaneous reporting ARME-P. Elsever, Amsterdam"},{"key":"242_CR26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2165\/00002018-200124130-00003","volume":"24","author":"P Th\u00fcrmann","year":"2001","unstructured":"Th\u00fcrmann P (2001) Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 24:961\u2013968","journal-title":"Drug Saf"},{"key":"242_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2125.1998.00685.x","volume":"45","author":"T Azaz-Livshits","year":"1998","unstructured":"Azaz-Livshits T, Levy M (1998) Computerized surveillance of adverse drug reactions in hospital: a pilot study. Br J Clin Pharmacol 45:309\u2013314","journal-title":"Br J Clin Pharmacol"},{"key":"242_CR28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2125.1999.00926.x","volume":"47","author":"I Tegeder","year":"1999","unstructured":"Tegeder I, Levy M, Muth-Selbach U (1999) Retrospective analysis of the frequency and recognition of adverse reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol 47:557\u2013564","journal-title":"Br J Clin Pharmacol"},{"key":"242_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2125.2000.00282.x","volume":"50","author":"H Bagheri","year":"2000","unstructured":"Bagheri H, Michel F, Lapeyre-Mestre M et al (2000) Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 50:479\u2013484","journal-title":"Br J Clin Pharmacol"},{"key":"242_CR30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s002280050571","volume":"54","author":"M Levy","year":"1999","unstructured":"Levy M, Azaz-Livshits T, Sadan B et al (1999) Computerized surveillance of adverse reactions in hospital: implementation. Eur J Clin Pharmacol 54:887\u2013892","journal-title":"Eur J Clin Pharmacol"},{"key":"242_CR31","first-page":"133","volume":"4","author":"G Salame","year":"1990","unstructured":"Salame G, P\u00e9r\u00e9 JC, Chaslerie A et al (1990) Liver injuries: a prospective study (abstract). J Clin Res Pharmacoepidemiol 4:133","journal-title":"J Clin Res Pharmacoepidemiol"},{"key":"242_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00228-004-0760-1","volume":"60","author":"A Dugu\u00e9","year":"2004","unstructured":"Dugu\u00e9 A, Bagheri H, Lapeyre-Mestre M, Tournamille JF et al (2004) Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 60:285\u2013292","journal-title":"Eur J Clin Pharmacol"},{"key":"242_CR33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.20176","volume":"77","author":"F Andersohn","year":"2004","unstructured":"Andersohn F, Bronder E, Klimpel A, Garbe E (2004) Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study. Am J Hematol 77 :316\u2013318","journal-title":"Am J Hematol"},{"key":"242_CR34","unstructured":"Assurance Maladie en ligne (2006) Les m\u00e9dicaments rembours\u00e9s en 2003 et 2004 par le r\u00e9gime g\u00e9n\u00e9ral d\u2019Assurance maladie. http:\/\/www.ameli.fr\/244\/DOC\/2333\/article.html"},{"key":"242_CR35","unstructured":"IMS (2006) Pharmaceutical market intelligence. http:\/\/www.imshealth.com"},{"key":"242_CR36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"The International Agranulocytosis and Aplastic Anemia Study","year":"1986","unstructured":"The International Agranulocytosis and Aplastic Anemia Study (1986) Risk of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749\u20131757","journal-title":"JAMA"},{"key":"242_CR37","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.1991.03470200059035","volume":"266","author":"DC Classen","year":"1991","unstructured":"Classen DC, Pestotnik SL, Evans RS, Bruke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266:2847\u20132851","journal-title":"JAMA"},{"key":"242_CR38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jamia.1994.95153428","volume":"1","author":"DW Bates","year":"1994","unstructured":"Bates DW, O\u2019Neil AC, Boyle D, Teich J, Chertow GM, Komaroff AL, Brennan TA (1994) Potential identifiability and preventability of adverse events using information systems. J Am Med Inform Assoc 1:404\u2013411","journal-title":"J Am Med Inform Assoc"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-006-0242-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0242-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T06:00:32Z","timestamp":1707544832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-006-0242-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,17]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2,7]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s00228-006-0242-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,17]]}}}